(Q34470074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25838375%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

review article

1 reference

title

Neoantigens in cancer immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25838375%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25838375%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Robert D Schreiber

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25838375%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

English

0 references

publication date

1 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25838375%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25838375%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

348

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25838375%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

69-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25838375%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

6230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25838375%20AND%20SRC:MED&resulttype=core&format=json

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Exploiting the curative potential of adoptive T-cell therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

The future of immune checkpoint therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

PD-1 blockade induces responses by inhibiting adaptive immune resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

The makings of a tumor rejection antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

21 January 2018

The cancer antigenome

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Epitope landscape in breast and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Exploiting the mutanome for tumor vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

High sensitivity of cancer exome-based CD8 T cell neo-antigen identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

The MHC class I peptide repertoire is molded by the transcriptome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

HLA-binding properties of tumor neoepitopes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Properties of MHC class I presented peptides that enhance immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

A vaccine targeting mutant IDH1 induces antitumour immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Adaptive immunity maintains occult cancer in an equilibrium state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Expression of tumour-specific antigens underlies cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Molecular and genetic properties of tumors associated with local immune cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Genetic basis for clinical response to CTLA-4 blockade in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Oncology meets immunology: the cancer-immunity cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Personal neoantigen cancer vaccines: The momentum builds

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Association of the autoimmune disease scleroderma with an immunologic response to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Signatures of mutational processes in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Immunotherapy at Large: The road to personalized cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA4971

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.AAA4971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25838375%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference